CClinicalTrials.gg
CompletedNCT06521320Updated Apr 24, 2025

Speaking Valve Combined With Airway Pressure Predicts Upper Airway Patency in Adult Tracheotomized Patients

An interventional study of speaking valve combined with airway pressure and Bronchoscopy in Tracheotomy, sponsored by Capital Medical University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-24.

Sponsored by Capital Medical University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Oct 2021, registered Jul 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
248
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study was aimed to evaluate whether speaking valve combined with airway pressure could predict upper airway patency non-invasively in prolonged tracheostomized patients, identify candidates who need following endoscopy examination.

Read the detailed description

Tracheotomy is an effective means of treating critically ill patients, but its postoperative management faces many challenges, especially in the assessment and monitoring of upper airway patency. Although the indwelling tracheostomy tube plays an important role in maintaining airway patency and assisting breathing, it may also cause a series of complications, including airway stenosis, granulation tissue hyperplasia, airway collapse, and laryngeal dysfunction. The patency of the upper airway after tracheotomy is directly related to the patient's spontaneous breathing ability and quality of life. Although the existing bronchoscopy provides accurate diagnostic information, its invasiveness and high cost limit its application in extensive and high-frequency monitoring. Finding a non-invasive, easy-to-operate and accurate alternative method is of great clinical significance.The speaking valve is a one-way valve placed at the end of the tracheostomy tube that directs airflow to the upper airway when the cuff is deflated. Airway pressure measurement is a simple, non-invasive method that measures the pressure inside the tracheostomy tube to infer airway patency and resistance levels. Combining the two for a systematic assessment of upper airway patency in tracheostomy patients may provide a new, efficient, non-invasive monitoring tool for the clinic. By comparing the results of speaking valve combined with airway pressure measurement with the "gold standard" bronchoscopy results, its sensitivity and accuracy in assessing upper airway patency are verified, which is expected to not only provide a non-invasive, easier-to-use bedside assessment tool, but also improve the quality of patient care and their quality of life. Our hospital's respiratory rehabilitation center has the appropriate infrastructure and professional staffing to conduct research safely and in a standardized manner.

02

Conditions studied

  • Tracheotomy

Keywords

  • upper airway patency
  • speaking valve
  • upper airway
  • prolonged tracheostomized patients
  • transtracheal end-expiratory pressure
03

In context

Lead sponsor

Capital Medical University is the lead sponsor of 283 studies on the registry; 92 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Weaned from ventilator more than 48 hours
  • No any organ failure
  • No sepsis
  • Stable heart rate and blood pressure
  • Lung infection under control
  • PCO2\<60mmHg
  • Patient and family sign informed consent form

Exclusion criteria

Exclusion Criteria:

  • Serious dysfunction of vital organs
  • Unable tolerance of cuff deflated
  • Laryngopharyngeal trauma
  • Known severe upper airway obstruction before referrer to our department
  • Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
248 participants (actual)

Study arms

  • Experimental
    Upper airway patency

    Upper airway patency confirmed by speaking valve combined with airway pressure measurement or bronchoscopy

    Diagnostic Test: speaking valve combined with airway pressure · Diagnostic Test: Bronchoscopy

  • Experimental
    Upper airway obstruction

    Upper airway obstruction confirmed by speaking valve combined with airway pressure measurement or bronchoscopy

    Diagnostic Test: speaking valve combined with airway pressure · Diagnostic Test: Bronchoscopy

Interventions

  • Diagnostic testspeaking valve combined with airway pressure

    All patients were given speaking valves and airway pressure was measured to assess upper airway patency.

  • Diagnostic testBronchoscopy

    The same examiner performed bronchoscopy on all patients to assess upper airway patency.

06

What researchers measure

Primary outcomes

  1. Upper airway patency

    Speaking valve combined with airway pressure protocol: After suction of oral and nasal secretion, the cuff was deflated. Then the speaking valve was placed. Supplement oxygen could be provided from nose. Connect a pressure measuring device for airway pressure. Then the tracheostomy tube was downsized according to patient's status (This decision was decided by a multidisciplinary team through consultation). Patients who could tolerate speaking valve and airway pressure\<10cmH2O were assumed Upper airway patency group. Patients who cannot tolerate the speaking valve or whose airway pressure is ≥10cmH2O even after downsizing the tracheostomy are in the Upper airway obstruction group. Bronchoscopy protocol: Use bronchoscopy through nose to observe the upper airway through the glottis and around the cuff. Patients with bilateral vocal cord distance \<3 mm or Cotton grade II or above were considered to have upper airway obstruction during bronchoscopy evaluation.

    Time frame: The patients started using the speaking valve combined with airway pressure measurement on the day of enrollment. After that, bronchoscopy should be performed within 48 hours.

07

Study locations

1 site
  • Beijing Rehabilitation Hospital of Capital Medical University
    Beijing, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06521320
Lead sponsor
Capital Medical University
Responsible party
Jingyi Ge (Principal Investigator, Capital Medical University) — Principal investigator
First posted
Jul 25, 2024
Start date
Oct 1, 2021
Primary completion
Apr 30, 2024
Completion
Sep 30, 2024
Last update
Apr 24, 2025

Study contacts

Jingyi Ge
principal investigator · specify unaffiliated

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion